nach oben

Reactions Weekly

Erschienen in:

01.12.2014 | Case report

Nimotuzumab

Rash, fever and chills following infusion: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Excerpt

During a retrospective study investigating the use of nimotuzumab to treat oesophageal squamous cell cancer (SCC), one patient was found to have developed skin rash and two patients were found to have developed infusion reactions of fever and chills [sex and ages not stated]. …

Chemotherapeutic treatment comprised either cisplatin and fluorouracil, paclitaxel and cisplatin, or a combination of both regimens

Ma N-Y, et al. Safety and efficacy of nimotuzumab in combination with radiotherapy for patients with squamous cell carcinoma of the esophagus. International Journal of Clinical Oncology 19: 297-302, No. 2, 1 Apr 2014 - ChinaPubMedCrossRef

Titel: Nimotuzumab
Rash, fever and chills following infusion: 3 case reports
Publikationsdatum: 01.12.2014
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2014
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-014-5967-z

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Nimotuzumab

Rash, fever and chills following infusion: 3 case reports

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

Mesalazine

Erlotinib

Ruxolitinib withdrawal

Voriconazole/hydrochlorothiazide/cotrimoxazole

Fingolimod

Genetic screening prevents carbamazepine-induced SJS/TEN